Global research trends in the field of Attention Deficit Hyperactivity Disorder biomarkers from 2013 to 2023: A bibliometric study
Abstract and keywords
Abstract:
The article presents a study on a comprehensive bibliometric analysis of the study of ADHD biomarkers from 2013 to 2023. Keyword clustering analysis has shown that the main research focuses on miRNA polymorphisms, DNA methylation (DNAm) and the brain-gut axis. These biomarkers can be used for early diagnosis of ADHD, treatment and evaluation of its effectiveness.

Keywords:
Attention deficit hyperactivity disorder, Biomarkers
Text
Text (PDF): Read Download
References

1. Salari N. [et al.] (2023), “The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis”, Italian Journal of Pediatrics, № 1 (49), p. 48.

2. Zanus C. [et al.] (2023), “Sleep Spindle-Related EEG Connectivity in Children with Attention-Deficit/Hyperactivity Disorder: An Exploratory Study”, Entropy, № 9 (25), p. 1244.

3. Velo S. [et al.] (2019), “Long-Term Effects of Multimodal Treatment on Psychopathology and Health-Related Quality of Life of Children With Attention Deficit Hyperactivity Disorder”, Frontiers in psychology, V. 10.

4. Cascone A. D. [et al.] (2023), “Brain tissue iron neurophysiology and its relationship with the cognitive effects of dopaminergic modulation in children with and without ADHD”, Developmental Cognitive Neuroscience, (63), p. 101274.

5. Sayal K. [et al.] (2018), “ADHD in children and young people: prevalence, care pathways, and service provision”, The Lancet Psychiatry, № 2 (5), pp. 175–186.

6. Waschbusch D. A. [et al.] (2022), “Inhibitory Control, Conduct Problems, and Callous Unemotional Traits in Children with ADHD and Typically Developing Children”, Developmental Neuropsychology, № 1 (47), pp. 42–59.

7. Cao C. [et al.] (2023), “Modeling Functional Brain Networks with Multi-Head Attention-based Region-Enhancement for ADHD Classification”, Proceedings of the 2023 ACM International conference on multimedia retrieval, ICMR 2023, pp. 362–369.

8. Blanco B. [et al.] (2023), “Cortical responses to social stimuli in infants at elevated likelihood of ASD and/or ADHD: A prospective cross-condition fNIRS study”, Cortex, (169), pp. 18–34.

9. Albajara Sáenz A., Villemonteix T., Massat I. (2019), “Structural and functional neuroimaging in attention‐deficit/hyperactivity disorder”, Developmental Medicine & Child Neurology, № 4 (61), pp. 399–405.

10. Batschelett M. A. [et al.] (2023), “Biomarkers of tic severity in children with Tourette syndrome: Motor cortex inhibition measured with transcranial magnetic stimulation”, Developmental medicine and child neurology, № 10 (65), pp. 1321–1331.

11. Torghabeh F. A., Hosseini S. A., Modaresnia Y. (2023), “Potential biomarker for early detection of ADHD using phase-based brain connectivity and graph theory”, Physical and engineering sciences in medicine.

12. Dypas L. B. [et al.] (2023), “Blood miRNA levels associated with ADHD traits in children across six European birth cohorts”, BMC psychiatry, № 1 (23), p. 696.

13. Xu X. [et al.] (2023), “Dexmedetomidine alleviates host ADHD-like behaviors by reshaping the gut microbiota and reducing gut-brain inflammation”, Psychiatry Research, V. 323.

14. Natsheh J. Y. [et al.] (2021), “The effects of the dopamine D2/3 agonist quinpirole on incentive value and palatability-based choice in a rodent model of attention-deficit/hyperactivity disorder”, Psychopharmacology, V. 238, № 11, pp. 3143–3153.

15. Carpentieri V. [et al.] (2023), “DAT1 5’-Un-Translated-Region Methylation Patterns as Bio-Markers of ADHD Psycho-Pathology: Contribution to Disease Prognosis and to Monitoring of a Successful Therapy”, Biomedicines, № 9 (11), p. 2546.

16. Vanicek T. [et al.] (2017), “Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET”, Human Brain Mapping, № 2 (38), pp. 792–802.

17. Lee S.-Y. [et al.] (2023), “Gut Leakage Markers and Cognitive Functions in Patients with Attention-Deficit/Hyperactivity Disorder”, Children-Basel, № 3 (10), p. 513.

18. Takahashi N. [et al.] (2023), “Interaction of genetic liability for attention deficit hyperactivity disorder (ADHD) and perinatal inflammation contributes to ADHD symptoms in children”, Brain, Behavior, & Immunity – Health, (30), p. 100630.

19. Subramani B. [et al.] (2023), “The Association of Bisphenol A and Parabens Exposure and Oxidative Stress in Attention-Deficit/Hyperactivity Disorder in Children and Adolescents”, Exposure and health.

20. Bratton T. K. [et al.] (2023), “Clinical Laboratory Approaches for Diagnoses of Sleep-Disordered Breathing and ADHD-Like Behavior in Children”, Journal of applied laboratory medicine, № 3 (8), pp. 568–582.

Login or Create
* Forgot password?